1. EP-1437 The prognostic significance of neutrophil / lymphocyte ratio for SBRT of cholangiocellular carcinoma. (April 2019) Authors: Bartl, N.; Adebahr, S.; Kirste, S.; Popp, I.; Schäfer, H.; Grosu, A.; Brunner, T.B.B.; Gkika, E. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1439 The role of FDG PET / CT in SBRT of primary tumors in the upper abdomen. (April 2019) Authors: Bartl, N.; Adebahr, S.; Kirste, S.; Popp, I.; Schäfer, H.; Grosu, A.; Brunner, T.B.; Gkika, E. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1050: SBRT in liver cancer versus TACE. A prospective, non-randomised observational trial (HERACLES). (November 2020) Authors: Brunner, T.; Gkika, E.; Bettinger, D.; Schultheiss, M.; Maruschke, L.; Bartl, N.; Kirste, S.; Bamberg, F.; Thimme, R.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗